Clinical Trials Logo

Abdominal Neoplasms clinical trials

View clinical trials related to Abdominal Neoplasms.

Filter by:

NCT ID: NCT03460561 Completed - Abdominal Cancer Clinical Trials

Peri-operative Rectus Sheath Block Versus TEA Abdominal Surgeries

Start date: August 1, 2016
Phase: Phase 3
Study type: Interventional

Thoracic epidural analgesia (TEA) can be considered the gold standard for postoperative analgesia in major abdominal surgeries, as proved by a lot of number of systematic reviews and meta-analyses have demonstrated that TEA was associated with superior postoperative analgesia, better patients' outcomes, reducing (systemic opiate requirements, ileus and pulmonary complications). The rectus sheath block (RSB) is effective for the surgeries that necessitated midline abdominal incisions as local anesthetics instillation will be within the posterior rectus sheath bilaterally providing intense analgesia for the middle anterior wall from the xiphoid process to the symphysis pubis in adults.

NCT ID: NCT03459417 Enrolling by invitation - Abdominal Pain Clinical Trials

Safety and Efficacy of Intrathecally Administered Magnesium Sulfate

Start date: January 1, 2018
Phase: Phase 3
Study type: Interventional

Magnesium sulfate safety profile has been documented by histopathological analysis in experimental studies. magnesium sulfate added to local anesthetics decrease postoperative opioid requirements.

NCT ID: NCT03453424 Active, not recruiting - Abdominal Pain Clinical Trials

Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA

Start date: June 30, 2017
Phase: Phase 3
Study type: Interventional

Dexmedetomidine if add to patient controlled epidural analgesia for patients undergoing major abdominal cancer surgery may improve its effects.

NCT ID: NCT03221335 Recruiting - Clinical trials for Digestive System Neoplasms

EUS-guided RFA for Solid Abdominal Neoplasms

Start date: May 2016
Phase: N/A
Study type: Interventional

Radiofrequency ablation has been used for treatment of solid neoplasms of the liver, lung, kidney and adrenal. Recently, EUS-guided RFA has become available and the device allows EUS-guided treatment of solid abdominal neoplasms. The procedure has been shown to be feasible in the porcine pancreas and was used to treat small groups of patients that are not suitable for surgery suffering from pancreatic cancers. The aim of the current study is to perform a multi-center prospective study on EUS-guided radiofrequency ablation (RFA) of solid abdominal neoplasms. The hypothesis is that EUS-guided RFA is safe, feasible and effective for treating solid abdominal neoplasms.

NCT ID: NCT03169439 Not yet recruiting - Oncology Clinical Trials

Irreversible Electroporation for Treatment of Solid Abdominal Tumors

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Irreversible electroporation (IRE) is a novel non-thermal ablation modality with promise for revolutionizing the treatment for local solid tumors. With the growing demand for alternative and less invasive treatments for localized tumors, the investigators have seen the development and investigation of several tissue ablation modalities, including radiofrequency ablation (RFA), microwave ablation, and cryoablation. Although these modalities have been efficacious, they have some disadvantages owing to their reliance on thermal energy for creating cell death.

NCT ID: NCT03165383 Completed - Abdominal Cancer Clinical Trials

The Analgesic Efficacy of Ultrasound Guided Transversus Abdominal Plane Block After Abdominal Cancer Surgeries

Start date: February 11, 2013
Phase: N/A
Study type: Interventional

Effective postoperative pain control results in decreased cardiac and pulmonary complications, patient satisfaction and early mobilization. A prospective, randomized comparative study was done of analgesic efficacy, opioid requirement and side effects in patients undergoing lower abdominal cancer surgeries. In Study Group Ultrasound guided Transversus Abdominis Plane (TAP) block was given and control Group no TAP block was given. Patient controlled analgesia (PCA) with intravenous morphine was given to both group patients, and total good PCA demands in both the groups was studied.

NCT ID: NCT03152695 Recruiting - Clinical trials for Symptomatic Abdominal Tumour

High-intensity Focused Ultrasound (HIFU) for the Symptom Relief of Inoperable Abdominal Tumors

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

High-intensity focused ultrasound (HIFU), a recently developed tumor ablation equipment, can be a non-invasive treatment for solid tumors. The principle of HIFU is physically focus the ultrasound point on the biological tissue to form high-intensity ultrasound focus, and kill tumor cells by the thermal effects, mechanical effects and acupuncture effects of the high-intensity ultrasound.

NCT ID: NCT03150992 Recruiting - Ovarian Cancer Clinical Trials

EDMONd - Elemental Diet in Bowel Obstruction

Start date: July 19, 2017
Phase: N/A
Study type: Interventional

A feasibility study to provide 'proof of concept' of Elemental Diet (ED) as an acceptable/ useful feeding option for patient with inoperable malignant bowel obstruction and to examine the impact of ED on quality of life

NCT ID: NCT03063112 Recruiting - Abdominal Cancer Clinical Trials

Radiofrequency and Chemical Neurolysis of Thoracic Splanchnic Nerve for Abdominal Cancer Pain

Start date: October 1, 2016
Phase: N/A
Study type: Interventional

The study compares between the efficacy, safety and impact on the quality of life of radiofrequency thermocoagulation and chemical neurolysis of bilateral thoracic splanchnic nerves in the management of refractory pain which developed in patients suffering from upper abdominal cancer.

NCT ID: NCT03060070 Completed - Clinical trials for Postoperative Analgesia

Ketamine Versus Dexmedetomidine With Local Anesthetic in TAP Block

Start date: March 10, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Comparing the analgesic effects of ketamine and dexmedetomidine when added to local anesthetic in TAP block for postoperative analgesia after lower abdominal cancer surgery.